252 related articles for article (PubMed ID: 32991215)
1. Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
Crombé A; Kind M; Ray-Coquard I; Isambert N; Chevreau C; André T; Lebbe C; Cesne AL; Bompas E; Piperno-Neumann S; Saada E; Bouhamama A; Blay JY; Italiano A;
AJR Am J Roentgenol; 2020 Dec; 215(6):1539-1548. PubMed ID: 32991215
[No Abstract] [Full Text] [Related]
2. Can radiomics improve the prediction of metastatic relapse of myxoid/round cell liposarcomas?
Crombé A; Le Loarer F; Sitbon M; Italiano A; Stoeckle E; Buy X; Kind M
Eur Radiol; 2020 May; 30(5):2413-2424. PubMed ID: 31953663
[TBL] [Abstract][Full Text] [Related]
3. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
5. MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis.
Subhawong TK; Feister K; Sweet K; Alperin N; Kwon D; Rosenberg A; Trent J; Wilky BA
Radiol Imaging Cancer; 2021 Jul; 3(4):e210016. PubMed ID: 34213370
[TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis and mutation stratification of desmoid-type fibromatosis on MRI using radiomics.
Timbergen MJM; Starmans MPA; Padmos GA; Grünhagen DJ; van Leenders GJLH; Hanff DF; Verhoef C; Niessen WJ; Sleijfer S; Klein S; Visser JJ
Eur J Radiol; 2020 Oct; 131():109266. PubMed ID: 32971431
[TBL] [Abstract][Full Text] [Related]
7. T
Crombé A; Périer C; Kind M; De Senneville BD; Le Loarer F; Italiano A; Buy X; Saut O
J Magn Reson Imaging; 2019 Aug; 50(2):497-510. PubMed ID: 30569552
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
9. High-Grade Soft-Tissue Sarcomas: Can Optimizing Dynamic Contrast-Enhanced MRI Postprocessing Improve Prognostic Radiomics Models?
Crombé A; Fadli D; Buy X; Italiano A; Saut O; Kind M
J Magn Reson Imaging; 2020 Jul; 52(1):282-297. PubMed ID: 31922323
[TBL] [Abstract][Full Text] [Related]
10. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
[TBL] [Abstract][Full Text] [Related]
11. Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics.
Carré A; Klausner G; Edjlali M; Lerousseau M; Briend-Diop J; Sun R; Ammari S; Reuzé S; Alvarez Andres E; Estienne T; Niyoteka S; Battistella E; Vakalopoulou M; Dhermain F; Paragios N; Deutsch E; Oppenheim C; Pallud J; Robert C
Sci Rep; 2020 Jul; 10(1):12340. PubMed ID: 32704007
[TBL] [Abstract][Full Text] [Related]
12. Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.
Colen RR; Rolfo C; Ak M; Ayoub M; Ahmed S; Elshafeey N; Mamindla P; Zinn PO; Ng C; Vikram R; Bakas S; Peterson CB; Rodon Ahnert J; Subbiah V; Karp DD; Stephen B; Hajjar J; Naing A
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33849924
[TBL] [Abstract][Full Text] [Related]
13. Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Kummar S; O'Sullivan Coyne G; Do KT; Turkbey B; Meltzer PS; Polley E; Choyke PL; Meehan R; Vilimas R; Horneffer Y; Juwara L; Lih A; Choudhary A; Mitchell SA; Helman LJ; Doroshow JH; Chen AP
J Clin Oncol; 2017 May; 35(14):1561-1569. PubMed ID: 28350521
[TBL] [Abstract][Full Text] [Related]
14. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma.
Li HM; Gong J; Li RM; Xiao ZB; Qiang JW; Peng WJ; Gu YJ
AJR Am J Roentgenol; 2021 Sep; 217(3):664-675. PubMed ID: 34259544
[No Abstract] [Full Text] [Related]
15. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: A preliminary study.
Gondim Teixeira PA; Chanson A; Verhaeghe JL; Lecocq S; Louis M; Hossu G; Blum A
Diagn Interv Imaging; 2019 Jan; 100(1):47-55. PubMed ID: 30037746
[TBL] [Abstract][Full Text] [Related]
16. Imatinib induces sustained progression arrest in RECIST progressive desmoid tumours: Final results of a phase II study of the German Interdisciplinary Sarcoma Group (GISG).
Kasper B; Gruenwald V; Reichardt P; Bauer S; Rauch G; Limprecht R; Sommer M; Dimitrakopoulou-Strauss A; Pilz L; Haller F; Hohenberger P
Eur J Cancer; 2017 May; 76():60-67. PubMed ID: 28282612
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study.
Zhang H; Mao Y; Chen X; Wu G; Liu X; Zhang P; Bai Y; Lu P; Yao W; Wang Y; Yu J; Zhang G
Eur Radiol; 2019 Jul; 29(7):3358-3371. PubMed ID: 30963272
[TBL] [Abstract][Full Text] [Related]
18. Soft Tissue Sarcomas: Preoperative Predictive Histopathological Grading Based on Radiomics of MRI.
Zhang Y; Zhu Y; Shi X; Tao J; Cui J; Dai Y; Zheng M; Wang S
Acad Radiol; 2019 Sep; 26(9):1262-1268. PubMed ID: 30377057
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Prognosis in Glioblastoma Using Radiomics Features of Dynamic Contrast-Enhanced MRI.
Pak E; Choi KS; Choi SH; Park CK; Kim TM; Park SH; Lee JH; Lee ST; Hwang I; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Sep; 22(9):1514-1524. PubMed ID: 34269536
[TBL] [Abstract][Full Text] [Related]
20. Association of MRI T2 Signal Intensity With Desmoid Tumor Progression During Active Observation: A Retrospective Cohort Study.
Cassidy MR; Lefkowitz RA; Long N; Qin LX; Kirane A; Sbaity E; Hameed M; Coit DG; Brennan MF; Singer S; Crago AM
Ann Surg; 2020 Apr; 271(4):748-755. PubMed ID: 30418203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]